rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
INDOCO REMEDIES LTD. - Announcement Under Regulation 30 (LODR)- Updates (USFDA Inspection At Indoco Remedies Limited'S Plant II (Sterile Facility) And Plant III (OSD Facility) At Goa)
Download announcement < Back
01 Mar 2023
We would like to inform you that the United States Food and Drug Administration (USFDA) has conducted GMP inspection of Plant II (Sterile Facility) and Plant III (OSD Facility) at Goa. The inspection was conducted from 20th February, 2023 to 28th February, 2023. The USFDA has issued Form 483 with four (4) observations, which will be addressed within stipulated time. We believe that this will not have an impact on the supplies and the existing revenues from these Facilities. The Company is committed to maintain compliances across all our facilities with cGMP quality standards at all times. This is for your information and record.
View all announcements for INDOCO REMEDIES LTD. Source: BSE India

Mutual Fund Selector

Find the fund that is right for you